相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Telmisartan prevented cognitive decline partly due to PPAR-γ activation
Masaki Mogi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Are we poised to target ACE2 for the next generation of antihypertensives?
Anderson J. Ferreira et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Blocking of angiotensin II is more than blocking of transforming growth factor-β
Christoph Daniel
KIDNEY INTERNATIONAL (2008)
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome
Benjamin S. Brooke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type-1 receptor blocker candesartan
Kana Tsukuda et al.
HYPERTENSION (2007)
IL-6 deficiency protects against angiotensin II - Induced endothelial dysfunction and hypertrophy
Laura I. Schrader et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
Li-Juan Min et al.
CARDIOVASCULAR RESEARCH (2007)
Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47phox gene expression in response to angiotensin II
Weihua Ni et al.
CIRCULATION RESEARCH (2007)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat
Yongzhong Wei et al.
HYPERTENSION (2007)
Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model
Jun Iwanami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats
Christine' S. Rigsby et al.
MICROVASCULAR RESEARCH (2007)
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Patrick G. Kehoe et al.
LANCET NEUROLOGY (2007)
Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states
Ronald D. Cohn et al.
NATURE MEDICINE (2007)
Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: Autocrine mechanisms in myofibroblasts and macrophages
Bruce D. Uhal et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
The incidence and implications of aldosterone breakthrough
Andrew S. Bomback et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system
Sayaka Nagata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes
Kenichi Matsushita et al.
HYPERTENSION (2006)
Aldosterone blockade: An emerging strategy for abrogating progressive renal disease
Murray Epstein
AMERICAN JOURNAL OF MEDICINE (2006)
Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance
C. Bubici et al.
ONCOGENE (2006)
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
Murray Epstein et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells
Chunyu Zeng et al.
CIRCULATION RESEARCH (2006)
Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway
Takeshige Kunieda et al.
CIRCULATION (2006)
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
Yoshitaka Nabeshima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2
Masaki Mogi et al.
HYPERTENSION (2006)
Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and β-arrestins
MGH Scott et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Antihypertensive medication use and incident Alzheimer disease - The Cache County Study
Ara S. Khachaturian et al.
ARCHIVES OF NEUROLOGY (2006)
Feasibility of treating prehypertension with an angiotensin-receptor blocker
S Julius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery
RA Bond et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure
Masaomi Nangaku
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells
LJ Min et al.
CIRCULATION RESEARCH (2005)
Aberrant ETB receptor regulation of AT1 receptors in immortalized renal proximal tubule cells of spontaneously hypertensive rats
CY Zeng et al.
KIDNEY INTERNATIONAL (2005)
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
L Yang et al.
JOURNAL OF HEPATOLOGY (2005)
Protective effect of the inhibition of the renin-angiotensin system on aging
N Basso et al.
REGULATORY PEPTIDES (2005)
Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES)
J Schrader et al.
STROKE (2005)
EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor
BR Shivakumar et al.
CELL BIOCHEMISTRY AND FUNCTION (2005)
Ligand-dependent complex formation between the Angiotensin II receptor subtype AT2 and Na+/H+ exchanger NHE6 in mammalian cells
L Pulakat et al.
PEPTIDES (2005)
Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells
CY Zeng et al.
HYPERTENSION (2005)
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats
Y Nagai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
D Dragun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C
H Yoshiji et al.
JOURNAL OF GASTROENTEROLOGY (2005)
c-Src regulates clathrin adapter protein 2 interaction with β-arrestin and the angiotensin II type 1 receptor during clathrin-mediated internalization
D Fessart et al.
MOLECULAR ENDOCRINOLOGY (2005)
Global burden of hypertension: analysis of worldwide data
PM Kearney et al.
LANCET (2005)
Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets
T Lau et al.
DIABETOLOGIA (2004)
Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity
M Furuhashi et al.
JOURNAL OF HYPERTENSION (2004)
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation
M Iwai et al.
CIRCULATION (2004)
Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP
S Nouet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II
YZ Zou et al.
NATURE CELL BIOLOGY (2004)
Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats
YH Wei et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice
T Shiuchi et al.
HYPERTENSION (2004)
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
R Bataller et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats
CY Zeng et al.
HYPERTENSION (2003)
Perturbation of D-1 dopamine and AT(1) receptor interaction in spontaneously hypertensive rats
CY Zeng et al.
HYPERTENSION (2003)
Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats
T Yamada et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor
D Dragun et al.
TRANSPLANTATION PROCEEDINGS (2003)
AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4
K Kanno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The ACCESS study -: Evaluation of acute candesartan cilexetil therapy in stroke survivors
J Schrader et al.
STROKE (2003)
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells
N Kurikawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats
A Kuno et al.
GASTROENTEROLOGY (2003)
Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR
CY Zeng et al.
HYPERTENSION (2003)
The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling
M Lopez-Ilasaca et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Angiotensin blockade prevents type 2 diabetes by formation of fat cells
AM Sharma et al.
HYPERTENSION (2002)
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver
G Paizis et al.
GASTROENTEROLOGY (2002)
Role of C-terminal cytoplasmic domain of the AT2 receptor in ligand binding and signaling
L Pulakat et al.
FEBS LETTERS (2002)
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors
J Janke et al.
DIABETES (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase:: an EPR spin trapping study
J Vásquez-Vivar et al.
BIOCHEMICAL JOURNAL (2002)
Rab5 association with the angiotensin II type 1A receptor promotes Rab5 GTP binding and vesicular fusion
JL Seachrist et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Intrarenal angiotensin II: Interstitial and cellular levels and site of production
JP van Kats et al.
KIDNEY INTERNATIONAL (2001)
The angiotensin II AT2 receptor is an AT1 receptor antagonist
S AbdAlla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Angiotensin II and renal fibrosis
SA Mezzano et al.
HYPERTENSION (2001)
Angiotensin III: a central regulator of vasopressin release and blood pressure
A Reaux et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2001)
Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis
CD Morrison et al.
HUMAN PATHOLOGY (2001)
ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth
TX Cui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
KK Griendling et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
S AbdAlla et al.
NATURE (2000)
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
S Nakamura et al.
KIDNEY INTERNATIONAL (2000)
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling
P Paradis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
